Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16Breast 7Thoracic 5Head & Neck 4Genitourinary 4Sarcoma 3Plasma cell 1NET 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neuroendocrine Tumors 3Stomach Neoplasms 1Neoplasms 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

repotrectinib 1pralsetinib 1lutetium Lu 177 dotatate 1lanreotide 1copper dotatate CU-64 1alectinib 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Lutetium-177 1Lutetium 1Ipilimumab 1Cryotherapy 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Surveys and Questionnaires × NET × Clear all
NCT04077372 2023-01-27

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Stanford University

Phase NA Terminated
12 enrolled
EndocrineGastrointestinalNETSarcoma

Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡